Search results for "Hydroxysteroid dehydrogenase"

showing 4 items of 14 documents

17beta-hydroxysteroid dehydrogenase-3 deficiency: a rare endocrine cause of male-to-female sex reversal.

2006

Deficiency of 17beta-hydroxysteroid dehydrogenase type 3 (17beta-HSD3), due to mutations in the gene encoding the enzyme, results in a rare autosomal recessive form of male-to-female sex reversal. Mutated genes encode an abnormal enzyme with absent or reduced ability to convert Delta4-androstenedione to testosterone in the testis. Affected individuals are genetically males who developed internal male Wolffian structures but female external genitalia. Such individuals are usually raised as females and diagnosis is made at puberty, when they show virilization. Correct diagnosis is mandatory to optimize treatment and follow-up. In the present paper we report the clinical history, endocrine eva…

Malemedicine.medical_specialty17-Hydroxysteroid DehydrogenasesEndocrinology Diabetes and MetabolismDisorders of Sex Development17beta-hydroxysteroid dehydrogenaseBiologyEndocrine System Diseaseschemistry.chemical_compoundEndocrinologyMolecular geneticsInternal medicinemedicineEndocrine systemHumansGeneTestosteroneVirilizationObstetrics and GynecologySex reversalmedicine.diseaseEndocrinologychemistryChild PreschoolAndrogensAndrogen insensitivity syndromeFemalemedicine.symptomGynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
researchProduct

Screening of Ovarian steroidogenic pathway in Ciona intestinalis and its modulation after Tributyltin exposure

2010

In this study, we have identified several ovarian steroids in Ciona with high similarity to vertebrate steroids and showed that cholesterol, corticosterone, dehydroepiandrosterone, estrone, estradiol-17beta, testosterone, pregnenolone, progesterone, have identical molecular spectra with vertebrate steroids. In addition, we have studied the effects of an endocrine disruptor (tributyltin: TBT) on these sex hormones and their precursors, ovarian morphology, and gene expression of some key enzymes in steroidogenic pathway in the ovary of Ciona. Ovarian specimens were cultured in vitro using different concentrations of TBT (10{sup -5}, 10{sup -4} and 10{sup -3} M). Ethanol was used as solvent co…

Settore BIO/07 - Ecologiaendocrine systemmedicine.medical_specialty17-Hydroxysteroid DehydrogenasesEstroneDehydroepiandrosteroneGene ExpressionOvaryBiologyEndocrine DisruptorsToxicologyGas Chromatography-Mass SpectrometryAdrenodoxin reductaseInternal medicinemedicineAnimalsCiona intestinalisTestosteroneGonadal Steroid HormonesProgesteronePharmacologyGC-MS Steroids Tributyltin Ciona intestinalis Evolution SteroidogenesisEstradiolAdrenodoxinOvaryDehydroepiandrosteronebiology.organism_classificationCiona intestinalisCionaFerredoxin-NADP Reductasemedicine.anatomical_structureEndocrinologyCholesterolEndocrine disruptorBiochemistrySex steroidPregnenolonePregnenoloneFemaleTrialkyltin CompoundsCorticosteronemedicine.drug
researchProduct

Small molecule modulators of amine oxidation, nuclear receptor signaling and glucuronidation : 3-phenylcoumarin as a scaffold of interest

2018

The costs of the drug development process are moderated as computer-aided drug design methods are able to expedite the steps required for lead identification. In fact, computational tools are nowadays virtually indispensable from target identification and validation to preclinical tests due to exponential growth of available information regarding both potential targets and small molecules. One such small molecule with growing number of variations is coumarin. Coumarin scaffold and its various derivatives continue to interest researchers for their vast application potential. Since naturally occurring coumarins are known for example for their antioxidant and anti-inflammatory properties, thos…

estrogeenitentsyymitlääkesuunnittelutumareseptoritmolekyylilääketiede3-phenylcoumarin17β-hydroxysteroid dehydrogenasecanceroksidoreduktaasitheterocyclic compoundsmonoamine oxidasekumariinitcomputer-aided drug designestrogen receptorinhibiittorit
researchProduct

16α-Iodo-3,17β-estradiol: A stable ligand for estrogen receptor determinations in tissues with high 17β-hydroxysteroid dehydrogenase activity

1983

Recently, the successful synthesis of radioiodinated 16 alpha-iodo-3,17 beta-estradiol-[125I] [125I]E2 was reported [1]. This new ligand has similar binding characteristics to the estrogen receptor (ER) [2-5] as the currently used tritium labeled estradiol [3H]E2. However, it offers several advantageous features: (a) high specific activity (theoretically 2,000 Ci/mmol) [1]; (b) minor problems with radioactive waste due to its short half life and (c) the possibility of simultaneous determination of ER and progesterone receptors (PgR) by double labeling with [125I]E2 and [3H]R5020 [6, 7]. As we are presently trying to determine ER and PgR in human placental cytosols we were interested in the …

medicine.medical_specialty17-Hydroxysteroid DehydrogenasesPlacentaEstrogen receptorEstroneOvaryLigandsTritiumEndometriumBiochemistryIodine Radioisotopeschemistry.chemical_compoundEndocrinologyPregnancyInternal medicinemedicineHumansHydroxysteroid dehydrogenaseReceptorEstradiolChemistryHalf-lifeLigand (biochemistry)Kineticsmedicine.anatomical_structureEndocrinologyReceptors EstrogenBiochemistryFemalehormones hormone substitutes and hormone antagonistsJournal of Steroid Biochemistry
researchProduct